Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallin

[1]  Andrew C. Li,et al.  An ADIOL-ERβ-CtBP Transrepression Pathway Negatively Regulates Microglia-Mediated Inflammation , 2011, Cell.

[2]  Z. Wang,et al.  Ethanol-induced neurodegeneration in NRSF/REST neuronal conditional knockout mice , 2011, Neuroscience.

[3]  Juntao Li,et al.  Identification of nigral dopaminergic neuron-enriched genes in adult rats , 2011, Neurobiology of Aging.

[4]  B. Barres,et al.  Astrocyte heterogeneity: an underappreciated topic in neurobiology , 2010, Current Opinion in Neurobiology.

[5]  S. Rivest.  Regulation of innate immune responses in the brain , 2009, Nature Reviews Immunology.

[6]  F. Gage,et al.  A Nurr1/CoREST Pathway in Microglia and Astrocytes Protects Dopaminergic Neurons from Inflammation-Induced Death , 2009, Cell.

[7]  E. Wawrousek,et al.  Suppression of GFAP toxicity by alphaB-crystallin in mouse models of Alexander disease. , 2009, Human molecular genetics.

[8]  W. Shao,et al.  Crucial roles of MZF‐1 in the transcriptional regulation of apomorphine‐induced modulation of FGF‐2 expression in astrocytic cultures , 2009, Journal of neurochemistry.

[9]  D. Hafler,et al.  Protective and therapeutic role for αB-crystallin in autoimmune demyelination , 2007, Nature.

[10]  K. McCarthy,et al.  Characterization of astrocyte‐specific conditional knockouts , 2007, Genesis.

[11]  S. Przedborski,et al.  Protocol for the MPTP mouse model of Parkinson's disease , 2007, Nature Protocols.

[12]  Jianwei Zhou,et al.  Apomorphine‐induced activation of dopamine receptors modulates FGF‐2 expression in astrocytic cultures and promotes survival of dopaminergic neurons , 2006, The FASEB Journal.

[13]  J. Serratosa,et al.  High‐yield isolation of murine microglia by mild trypsinization , 2003, Glia.

[14]  Jia-wei Zhou,et al.  Apomorphine induces trophic factors that support fetal rat mesencephalic dopaminergic neurons in cultures , 2002, The European journal of neuroscience.

[15]  E. Tamm,et al.  AlphaB-crystallin in lens development and muscle integrity: a gene knockout approach. , 2001, Investigative ophthalmology & visual science.

[16]  K. Willecke,et al.  hGFAP‐cre transgenic mice for manipulation of glial and neuronal function in vivo , 2001, Genesis.

[17]  A. Privat,et al.  Inactivation of the Glial Fibrillary Acidic Protein Gene, But Not That of Vimentin, Improves Neuronal Survival and Neurite Growth by Modifying Adhesion Molecule Expression , 2001, The Journal of Neuroscience.

[18]  Lars Farde,et al.  Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain , 2000, Neurobiology of Aging.

[19]  S. Tonegawa,et al.  Dopamine D3 Receptor Mutant Mice Exhibit Increased Behavioral Sensitivity to Concurrent Stimulation of D1 and D2 Receptors , 1997, Neuron.

[20]  R. G. Allen,et al.  Pituitary Lactotroph Hyperplasia and Chronic Hyperprolactinemia in Dopamine D2 Receptor-Deficient Mice , 1997, Neuron.

[21]  A. Björklund,et al.  Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[22]  C. Gerfen,et al.  Altered striatal function in a mutant mouse lacking D1A dopamine receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[23]  A. Bal,et al.  Evidence for dopamine D2 receptor mRNA expression by striatal astrocytes in culture: in situ hybridization and polymerase chain reaction studies. , 1994, Brain research. Molecular brain research.

[24]  W. H. Oertel,et al.  Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: A combined retrograde tracing and immunocytochemical study in the rat , 1994, Neuroscience.

[25]  K. Leenders,et al.  Dopamine D2 Receptors in Normal Human Brain: Effect of Age Measured by Positron Emission Tomography (PET) and [11C]‐Raclopride a , 1993, Annals of the New York Academy of Sciences.

[26]  K. Leenders,et al.  Effect of age on D2 dopamine receptors in normal human brain measured by positron emission tomography and 11C-raclopride. , 1993, Archives of neurology.

[27]  T. Iwaki,et al.  αB-crystallin is expressed in non-lenticular tissues and accumulates in Alexander's disease brain , 1989, Cell.

[28]  J. Langston,et al.  Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.

[29]  Neuron.  Immune Activation in Brain Aging and Neurodegeneration: Too Much or Too Little? , 2010 .

[30]  Andrea Crotti,et al.  Nuclear receptors, inflammation, and neurodegenerative diseases. , 2010, Advances in immunology.

[31]  Bradford Z. Mahon,et al.  Category-Specific Organization in the Human Brain Does Not Require Visual Experience , 2009, Neuron.

[32]  A. Griffioen,et al.  AB-crystallin promotes tumor angiogenesis by increasing vascular survival during tube morphogenesis. Commentary , 2008 .

[33]  T. Iwaki,et al.  Alpha B-crystallin is expressed in non-lenticular tissues and accumulates in Alexander's disease brain. , 1989, Cell.

[34]  Philip Seeman,et al.  Human brain dopamine receptors in children and aging adults , 1987, Synapse.